Five Dividend-Paying Giants Lead Goldman Sachs Conviction List
Five dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
This intro asks which is better for beginners in 2026: manual or robo investing, covering simplicity, risk, and learning curve for new investors.
25,920 articlesFive dividend-paying giants have sat on Goldman Sachs' Conviction List the longest, underscoring steady income as mar...
Shopify and Fiserv weigh AI bets and execution paths, signaling distinct strategies for growth, margins, and merchant...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
1Win unveils a World Cup mega tournament offering 5 million USDT in rewards. The promotion runs June 11 to July 19, 2...
Camtek reports Q1 2026 revenue of $121.66 million with a booming backlog worth over $260 million for 2026-27, undersc...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
A new wave of AI infrastructure spending from Meta Platforms is shaping the outlook for Nvidia and the cloud ecosyste...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
Investors are weighing value exposure against high-quality income. This piece analyzes why SCHD may outperform VTV on...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...